Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / India

Eisai Offshores Manufacturing To India

July 2010 | Industry Trend Analysis

To read the full article, please choose one of the following options:

Subcribers please log in

BMI Core View: Offshoring manufacturing to low cost bases will accelerate. Multinational drugmakers are looking to cut costs ahead of the patent cliff and production is being shifted to emerging markets. The key attributes of a manufacturing hub are a favourable tax regime, political stability, a strategic location close to consumers and affordable utilities, real estate and waste management systems.